Atara Biotherapeutics, Inc. (ATRA)
5.40
+0.49
(+9.98%)
USD |
NASDAQ |
Mar 03, 15:37
Atara Biotherapeutics Price : 5.40 for March 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 321.20 |
| Pfizer Inc. | 26.74 |
| Vertex Pharmaceuticals, Inc. | 475.21 |
| AbbVie, Inc. | 234.97 |
| ACADIA Pharmaceuticals, Inc. | 22.83 |
Price Related Metrics
| PE Ratio | 2.463 |
| PS Ratio | 0.4213 |
| Earnings Yield | 40.60% |
| Market Cap | 38.94M |
| Operating PE Ratio | 1.703 |
| Normalized PE Ratio | 1.854 |